BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34290672)

  • 1. Usefulness of FT3 to FT4 Ratio to Predict Mortality in Euthyroid Patients With Prior Cardiovascular Events Undergoing PCI: Five-Year Findings From a Large Single-Center Cohort Study.
    Yuan D; Jia S; Zhu P; Zhang C; Liu Y; Liu R; Xu J; Tang X; Zhao X; Gao R; Yang Y; Xu B; Gao Z; Yuan J
    Front Endocrinol (Lausanne); 2021; 12():700349. PubMed ID: 34290672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free triiodothyronine to free thyroxine ratio as a marker of poor prognosis in euthyroid patients with acute coronary syndrome and diabetes after percutaneous coronary intervention.
    Wang S; Wang Y; Sun S; Li F; Zhao W; Li X; Ye M; Niu Y; Wu X
    Front Endocrinol (Lausanne); 2024; 15():1322969. PubMed ID: 38654927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Value of Free Triiodothyronine to Free Thyroxine Ratio in Euthyroid Patients With Myocardial Infarction With Nonobstructive Coronary Arteries.
    Gao S; Ma W; Huang S; Lin X; Yu M
    Front Endocrinol (Lausanne); 2021; 12():708216. PubMed ID: 34394005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of the fT3/fT4 ratio and its combination with the GRACE risk score in predicting the prognosis in euthyroid patients with acute myocardial infarction undergoing percutaneous coronary intervention: a prospective cohort study.
    Yu T; Tian C; Song J; He D; Wu J; Wen Z; Sun Z; Sun Z
    BMC Cardiovasc Disord; 2018 Sep; 18(1):181. PubMed ID: 30200880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of free triiodothyronine (FT3) to free thyroxine (FT4) ratio in long-term outcomes of euthyroid patients with three-vessel coronary artery disease.
    Yuan D; Zhang C; Jia S; Liu Y; Jiang L; Xu L; Zhang Y; Xu J; Xu B; Hui R; Gao R; Gao Z; Song L; Yuan J
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):579-586. PubMed ID: 33250369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High free triiodothyronine and free-triiodothyronine-to-free-thyroxine ratio levels are associated with metabolic syndrome in a euthyroid population.
    Urrunaga-Pastor D; Guarnizo-Poma M; Moncada-Mapelli E; Aguirre LG; Lazaro-Alcantara H; Paico-Palacios S; Pantoja-Torres B; Benites-Zapata VA;
    Diabetes Metab Syndr; 2018; 12(2):155-161. PubMed ID: 29254889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
    Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
    BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of free triiodothyronine to free thyroxine ratio on contrast-associated acute kidney injury and poor prognosis in euthyroid patients after percutaneous coronary intervention.
    Zeng JL; Zhang LW; Liang WJ; You Z; Chen JH; Chen LC; Lin KY; Guo Y
    Int Urol Nephrol; 2024 Apr; ():. PubMed ID: 38578391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of Thyroid Hormones With Cardiogenic Shock and Prognosis in Patients with ST Segment Elevation Myocardial Infarction (STEMI) Treated with Primary PCI.
    Xue Y; Zhu Y; Shen J; Zhou W; Xiang J; Xiang Z; Wang L; Luo S
    Am J Med Sci; 2022 Mar; 363(3):251-258. PubMed ID: 34547284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FT3/FT4 Enhances Risk Assessment in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Based on GRACE 2.0 Score.
    Han C; Wang L; Liu C; Qi W; Zhang R; Wei A; Yang H; Wang C; Hu Y; Xu J; Zhang Y; Li W; Li T; Jin D; Cong H; Zhang J
    Angiology; 2023 Oct; ():33197231199228. PubMed ID: 37876209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study.
    van den Berg EH; van Tienhoven-Wind LJ; Amini M; Schreuder TC; Faber KN; Blokzijl H; Dullaart RP
    Metabolism; 2017 Feb; 67():62-71. PubMed ID: 28081779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FREE THYROID HORMONES AND MORTALITY IN CAUCASIANS UNDERGOING ANGIOGRAPHY: THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH (LURIC) STUDY.
    Merke A; Merke J; Silbernagel G; März W
    Endocr Pract; 2017 Mar; 23(3):288-298. PubMed ID: 27849383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prognostic value of free triiodothyronine/free thyroxine ratio in patients hospitalized with heart failure].
    Zhou P; Huang LY; Zhai M; Huang Y; Zhuang XF; Liu HH; Zhang YH; Zhang J
    Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(22):1679-1684. PubMed ID: 37302858
    [No Abstract]   [Full Text] [Related]  

  • 14. FT3/FT4 ratio is correlated with all-cause mortality, cardiovascular mortality, and cardiovascular disease risk: NHANES 2007-2012.
    Lang X; Li Y; Zhang D; Zhang Y; Wu N; Zhang Y
    Front Endocrinol (Lausanne); 2022; 13():964822. PubMed ID: 36060933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects.
    Roef GL; Rietzschel ER; Van Daele CM; Taes YE; De Buyzere ML; Gillebert TC; Kaufman JM
    Thyroid; 2014 Feb; 24(2):223-31. PubMed ID: 24032604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention.
    Yang J; Tang YD; Zheng Y; Li C; Zhou Q; Gao J; Meng X; Zhang K; Wang W; Shao C
    Front Endocrinol (Lausanne); 2021; 12():710240. PubMed ID: 34489866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free triiodothyronine/free thyroxine (FT3/FT4) ratio is strongly associated with insulin resistance in euthyroid and hypothyroid adults: a cross-sectional study.
    Štěpánek L; Horáková D; Štěpánek L; Janout V; Janoutová J; Bouchalová K; Martiník K
    Endokrynol Pol; 2021; 72(1):8-13. PubMed ID: 33125689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FT4/FT3 ratio: A novel biomarker predicts coronary microvascular dysfunction (CMD) in euthyroid INOCA patients.
    Zhang H; Che W; Shi K; Huang Y; Xu C; Fei M; Fan X; Zhang J; Hu X; Hu F; Qin S; Zhang X; Huang Q; Yu F
    Front Endocrinol (Lausanne); 2022; 13():1021326. PubMed ID: 36187090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower free triiodothyronine levels within the reference range are associated with higher cardiovascular mortality: An analysis of the NHANES.
    Neves JS; Leitão L; Baeta Baptista R; Bigotte Vieira M; Magriço R; Viegas Dias C; Oliveira A; Falcão-Pires I; Lourenço A; Carvalho D; Leite-Moreira A
    Int J Cardiol; 2019 Jun; 285():115-120. PubMed ID: 30879936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. J-shaped association of free triiodothyronine to free thyroxine ratio with 5-year mortality among patients with chronic kidney disease: a prospective cohort study.
    Li S; Zeng M
    Int Urol Nephrol; 2023 Oct; 55(10):2567-2578. PubMed ID: 36917414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.